LY2874455

LY2874455 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2874455, covering 2019-06-12 to 2019-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of LY2874455 in Participants With Advanced Cancer [Phase 1]